Status: Recruiting
Open Label, Dose Escalation, Repeat Dose Study Evaluating YCT-529 in Healthy Males
This is a Phase 1b/2a open-label, dose escalation 3 part-study, 28-day, 90-day or 180 day repeat dose study of YCT-529 in healthy males who have decided to have a vasectomy and are waiting for the procedure and for men who have decided not to father children in the future. The study is aimed at evaluating the safety, tolerability, pharmacokinetics, pharmacodynamics and to assess sexual function and mood.
Participants needed: 88
Trial details
Phase: Phase 1, Phase 2Age: 28-70Biological sex: MaleType: InterventionalSponsor: YourChoice Therapeutics, Inc.Updated: Feb 13, 2026Locations: 1
Eligibility criteria
Participant in good health as confirmed by physical examination, medical history... [+14]
Men participating in another clinical study involving an investigational drug wi... [+22]